ACADIAN ASSET MANAGEMENT LLC - IRADIMED CORP ownership

IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 70 filers reported holding IRADIMED CORP in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of IRADIMED CORP
ValueSharesWeighting
Q3 2023$8,062
-7.1%
181,7830.0%0.03%
-5.6%
Q2 2023$8,674
+22.4%
181,783
+0.9%
0.04%
+16.1%
Q1 2023$7,084
+50.9%
180,076
+8.4%
0.03%
+34.8%
Q4 2022$4,695
-99.9%
166,053
+0.2%
0.02%
-14.8%
Q3 2022$4,981,000
-11.5%
165,7910.0%0.03%
-6.9%
Q2 2022$5,627,000
-12.5%
165,791
+15.5%
0.03%
+7.4%
Q1 2022$6,432,000
+143.0%
143,538
+150.4%
0.03%
+170.0%
Q4 2021$2,647,000
+266.1%
57,330
+165.9%
0.01%
+233.3%
Q3 2021$723,000
+1802.6%
21,564
+1552.4%
0.00%
Q2 2021$38,000
-73.2%
1,305
-80.4%
0.00%
-100.0%
Q3 2020$142,000
-83.5%
6,667
-82.0%
0.00%
-75.0%
Q2 2020$860,000
+5.5%
37,080
-2.8%
0.00%
-20.0%
Q1 2020$815,000
+21.5%
38,157
+33.2%
0.01%
+66.7%
Q4 2019$671,000
+86.4%
28,647
+67.1%
0.00%
+50.0%
Q3 2019$360,000
+12.1%
17,145
+9.3%
0.00%0.0%
Q2 2019$321,000
-61.6%
15,684
-47.3%
0.00%
-50.0%
Q1 2019$836,000
+27.2%
29,764
+10.9%
0.00%
+33.3%
Q4 2018$657,000
+295.8%
26,844
+500.7%
0.00%
+200.0%
Q3 2018$166,000
+453.3%
4,469
+205.5%
0.00%
Q2 2018$30,000
-53.1%
1,463
-65.4%
0.00%
Q4 2017$64,000
+220.0%
4,234
+100.0%
0.00%
Q3 2017$20,000
-90.4%
2,117
-75.3%
0.00%
-100.0%
Q3 2015$209,0008,5780.00%
Other shareholders
IRADIMED CORP shareholders Q1 2020
NameSharesValueWeighting ↓
Nine Ten Capital Management LLC 715,877$32,100,0004.18%
Soleus Capital Management, L.P. 430,051$19,283,0002.49%
RESOURCE CONSULTING GROUP INC 128,000$5,740,0001.99%
RK Capital 213,200$9,560,0001.88%
Capital Impact Advisors, LLC 22,797$1,022,0000.74%
G2 Investment Partners Management LLC 61,326$2,750,0000.65%
EAM Investors, LLC 76,179$3,416,0000.64%
Ranger Investment Management 193,306$8,668,0000.55%
EAM Global Investors LLC 42,885$1,923,0000.36%
Hillsdale Investment Management Inc. 121,500$5,448,0000.35%
View complete list of IRADIMED CORP shareholders